Fri, 01st Jan 2021 12:17
NEW DELHI, Jan 1 (Reuters) - India's drug regulator on
Friday approved a coronavirus vaccine developed by AstraZeneca
and Oxford University for emergency use, two sources
with knowledge of the matter told Reuters.
A representative of India's Central Drugs Standard Control
Organization (CDSCO), whose experts were meeting for the second
time this week, declined to comment.
(Reporting by Krishna N. Das and Nigam Prusty
Editing by Gareth Jones)
April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negoti...
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:
(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while a...
(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe a...
(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', ...
Astrazeneca (AZN)